SCHEMBL6314890

SCHEMBL6314890

NCCCn1c(-c2ccccc2)nc2cc(Cl)ccc2c1=O

nearest known ligand 0.86

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.86
ALDH1A1 P00352 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
MAPT P10636 4/20 0.55
TP53 P04637 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
CASR P41180 1/20 0.52
POLB P06746 3/20 0.52
LMNA P02545 1/20 0.51
RECQL P46063 1/20 0.51
RAB9A P51151 1/20 0.51
GAA P10253 1/20 0.50
JAK2 O60674 1/20 0.50
JAK1 P23458 1/20 0.50
TYK2 P29597 1/20 0.50
JAK3 P52333 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6314802 0.98 EGFR (0.83) EGFRALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL6307813 0.92 EGFR (0.73) EGFRALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL6306955 0.92 EGFR (0.72) EGFRALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL6308088 0.90 EGFR (0.70) EGFRALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL6307692 0.89 EGFR (0.69) EGFRALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL6315683 0.89 EGFR (0.69) EGFRALDH1A1MAPTTP53RXFP1
SCHEMBL6313171 0.89 EGFR (0.69) EGFRSMN1; SMN2MAPTTP53RXFP1
SCHEMBL6314797 0.87 EGFR (0.66) EGFRALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL6309029 0.86 CASR (0.68) EGFRALDH1A1SMN1; SMN2MAPTCASR
SCHEMBL6313852 0.85 EGFR (0.64) EGFRALDH1A1SMN1; SMN2MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6890930-B1 Quinazolinones 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2005-05-10 US disclosed
EP-1216235-A1 QUINAZOLINONES MERCK PATENT GmbH (DE) 2002-06-26 EP disclosed
WO-2001023365-A1 QUINAZOLINONES MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed